Joseph P. Hagan
2019 - Regulus Therapeutics
In 2019, Joseph P. Hagan earned a total compensation of $2M as President & Chief Executive Officer at Regulus Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $860,652 |
|---|---|
| Option Awards | $540,342 |
| Salary | $535,600 |
| Stock Awards | $69,079 |
| Other | $8,610 |
| Total | $2,014,283 |
Hagan received $860.7K in non-equity incentive plan, accounting for 43% of the total pay in 2019.
Hagan also received $540.3K in option awards, $535.6K in salary, $69.1K in stock awards and $8.6K in other compensation.
Rankings
In 2019, Joseph P. Hagan's compensation ranked 5,885th out of 13,971 executives tracked by ExecPay. In other words, Hagan earned more than 57.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,885 out of 13,971 | 58th |
Division Manufacturing | 2,208 out of 5,701 | 61st |
Major group Chemicals And Allied Products | 801 out of 2,200 | 64th |
Industry group Drugs | 676 out of 1,886 | 64th |
Industry Pharmaceutical Preparations | 498 out of 1,398 | 64th |
Source: SEC filing on April 29, 2020.
Hagan's colleagues
We found three more compensation records of executives who worked with Joseph P. Hagan at Regulus Therapeutics in 2019.
News
Regulus Therapeutics CEO Joseph Hagan's 2021 pay falls 22% to $1.8M
April 27, 2022
Regulus Therapeutics CEO Joseph Hagan's 2020 pay rises 16% to $2.3M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
April 29, 2020
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019